We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > nexium

News List

Cipla receives final approval for generic version of AstraZeneca Pharmaceutical’s Nexium (Esomeprazole for Oral Suspension 10mg, 20mg and 40mg) expresspharma
March 27, 2020
With this, Cipla has become the first company to file for the 10 mg variant strength of the product.
Grünenthal buys certain rights to AZ’s Nexium and Vimovo for $922m pharmaphorum
December 18, 2018
AstraZeneca has agreed to sell some of the rights to its drugs Nexium and Vimovo to Grünenthal for an upfront payment of $922 million.
AZ sheds Nexium, Vimovo rights to Gruenenthal pharmatimes
November 05, 2018
AstraZeneca is continuing to shed products outside the scope of its three core therapy areas with the sale of certain rights to Nexium...
AstraZeneca signs $922m licensing deal with Grünenthal pharmaceutical-technology
November 01, 2018
AstraZeneca has announced plans to sell certain prescription medicine rights for Nexium and Vimovo to German pharmaceutical company Grünenthal Group under a $922m deal...